. 2020 Nov 7;37(5):760–765. doi: 10.5114/ada.2020.100485

Table 1.

Immunological data of an A-T patient with cutaneous and systemic granulomatosis

Immunological profile
Haematology:
	HGB 11.4 g/dl, HCT 34.9%, RBC 4.48 × 10⁶/µl, WBC 2.66 × 10³/µl, PLT 158 × 10³/µl
	WBC differential: lymphocytes 26% (0.7 × 10³/µl), neutrophils 59% (1.58 × 10³/µl) monocytes 11% (0.27 × 10³/µl), eosinophils 3% (0.06 × 10³/µl), basophils 1% (0.03 × 10³/µl)
Immunoglobulins:
	IgG 685 mg/dl (an IgG through level during IVIg therapy), IgA < 5 mg/dl, IgM 1517 mg/dl
Peripheral blood lymphocyte flow cytometric immunophenotyping:
	Lymphocytes 15% (1159 cell/µl)↓
	CD3⁺ 70.4% (815 cell/µl)↓, CD4⁺ 27.3% (316 cell/µl)↓, CD8⁺ 20.2% (233 cell/µ)↓
	CD4+CD45RA+CD31+ 4.4% (14 cell/µl)↓↓, CD4+CD45RA+CD27+ 14.4% (45 cell/µl)↓↓
	CD4⁺CD45RO⁺CD27⁺ 42.0% (133 cell/µl), CD4⁺CD45RO⁺CD27^– 27.7% (88 cell/µl)↑↑
	CD4⁺CD127^–CD25⁺⁺ 4.5% (14 cell/µl)
	CD8⁺CD45RA⁺197⁺CD27⁺ 24.8% (58 cell/µl)↓
	CD8⁺CD45RO⁺CD197⁺CD27⁺ 69.6 (162 cell/µl)↑↑, CD8⁺CD45RO⁺CD197^–CD27^– 3.6% (8 cell/µl)
	CD3⁺TCRαβ⁺ 67.6% (551 cell/µl↓↓, CD3⁺TCRγδ⁺ 32.4% (264 cell/µl)↑↑
	CD3⁺HLA-DR⁺ 26% (212 cell/µl)↑
	NK 27.8% (322 cell/µl)↑, NK-T 11% (128 cell/µl)↑
	CD19⁺ 1.2% (14 cell/µl)↓↓, CD19⁺CD38⁺⁺sIgM⁺⁺ 5.0% (1 cell/µl)
	CD19⁺CD21^lo 15.3% (2.1 cell/µl)↑
	CD19⁺CD38^loCD21^lo 9.7% (1 cell/µl)↑
	CD19⁺CD27^-sIgD⁺ 74.8% (11 cell/µl)↓↓
	CD19⁺CD27⁺sIgD⁺ 21.0% (3 cell/µl)↓↓
	CD19⁺CD27⁺sIgD^– 3.7% (1 cell/µl)↓↓, CD19⁺CD27⁺sIgD^–sIgM⁺ 44.4%↑↑
	CD19⁺CD38^hisIgM^– 0.9% (0 cell/µl)↓↓